Updates, advisories and surprises By MarketWatch Last Update: 4:31 PM ET Apr 10, 2008 (4:18 PM ET) BOSTON (MarketWatch) — Genentech Inc.(DNA)reported a 12% boost in its bottom-line late Thursday, due largely to increased sales for its cancer medications. For the quarter ended March 31, Genentech posted net income of $790 million, compared with $706 million for the previous year’s quarter. […] For more visit Source:www.investment-blog.net

Share This

Share This

This entry was posted on Saturday, April 12th, 2008 at 2:08 am and is filed under Investment News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.